drugset / Trial / NCT04291066

Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients

NCT04291066

Phase 2 Completed 92 enrolled HonorHealth Research Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the administration of N-Acetyl-cysteine in combination with multi-vitamins/minerals in geriatric population (\>60 years of age) who have experienced a traumatic brain injury.

Timeline

Start
2019-09-01
Primary completion
2020-04-30
Completion
2021-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule Oral